| SOP Reference Number & Title | Appendix Title |
| S-1002: SOP UHL Documentation review process | Appendix 1 – Sponsor Request Form
Appendix 2 – Peer Review |
|
S-1003: SOP UHL Sponsor risk assessment and management
| Appendix 1 – Risk Matrix Score Tables
Appendix 2 – Risk Assessment Form
Appendix 4 – Risk Assessment Flow Chart
Appendix 5 – UHL Sponsor Review Risk Assessed Studies Checklist
Appendix 6 – Sponsor Review Non-Risk Assessed Checklist |
|
S-1004: SOP for development safety update report for CTIMPS
| Appendix 1 – DSUR Template
Appendix 2 – DSUR Reporting Timeframe Working Illustration
Appendix 3 – DSUR Reporting Timeframe Working Instructions |
|
S-1005: SOP for management of contracts
|
Appendix 1 – UHL Contracts Review and Approval Process
|
|
S-1006: SOP for informed consent
| Appendix 1 – Blank DoA Signature Log
Appendix 2 – Assent Signature Log
Appendix 3 – Assent Consent Log
Appendix 4 – Witness Consent Form Template
Appendix 5 Consent Witness Statement
Appendix 6 – Pre-Consent activity proforma
Appendix 7 – eSignature Log |
|
SOP S-1007 UHL Monitoring
|
Appendix 1 – Monitoring Plan
Template
Appendix 1a – Monitoring Plan
Template Medical Devices
Appendix 2 – Monitoring
Strategy Table
Appendix 3 – Contact
Monitoring Log
Appendix 4 – Trial Monitoring
Visit Log
Appendix 5 – UHL Template
Schedule Source Data
Appendix 6 – CTIMP Monitoring
Visit Report Appendix 6a – Monitoring
Visit Report Non CE Marked Medical Devices
Appendix 7 – Pharmacy visit
report
Appendix 8 – Non-CTIMP Interim Site Audit checklist
& Response
Appendix 8a – CE Marked
Medical device Interim Site Audit checklist & Response Doc
|
|
SOP S-1008 UHL Training for Staff Engaged in Research
| Appendix 1 – SOPs Read Log for UHL Sponsored Studies
Appendix 2 – Protocol Training Log |
|
SOP S-1009 UHL SAEs_SUSARS
| Appendix 1 – Pregnancy Reporting Form
Appendix 2 – Multicentre line listing
Appendix 3 – SAE Tracking Log
Appendix 4 – UHL SAE Process Flowchart
Appendix 5 – Template Sponsor SAE Email
Appendix 6 – Multicentre line listing CTIMP Appendix 7 – eSUSAR Guidance
Appendix 8 – UHL SUSAR Process Flowchart
Appendix 9 – UHL Expedited Safety Report Notification Email
Appendix 10 – UHL Suspected SUSAR Unblinding Process Flowchart
UHL SAE Form A Completion Guidance Document CTIMP
UHL SAE Form B Completion Guidance Document Non-CTIMP
UHL SAE Reporting Form A CTIMP
UHL SAE Reporting Form B Non CTIMP
|
|
SOP S-1010 UHL Chief Investigator Responsibilities
| Appendix 1 – Roles and Responsibilities of CI Agreement |
|
S-1011: SOP for site initiation of CTIMP research
| Appendix 1a – Site Initiation Checklist & Outstanding Issues Report
Appendix 2 – Pharmacy Site Initiation Visit Checklist
Appendix 3 – SOP Read Log for UHL Sponsored Studies
Appendix 4 – Subject Screening Log
Appendix 5 – Subject Enrolment Log
Appendix 6 – Site Initiation Checklist & Outstanding Issues Report Non-CTIMP
Appendix 6a – UHL Site Initiation Checklist & Outstanding Issues Report – CE Marked Medical Device Studies
Appendix 7 – Site Initiation Checklist Guidance Non-CTIMP
Appendix 7a – Site Initiation Checklist Guidance – CE Marked Medical Device Studies
Appendix 8 – Investigational Medical Device Accountability Log |
|
SOP S-1012 UHL CAPA
| Appendix 1 – CAPA Form |
|
SOP S-1013 UHL Serious Breaches
| Appendix 1 – Serious Breach Notification form
Appendix 2 – Template file note
Appendix 3 – Protocol Deviation Tracking Log |
|
SOP S-1014 UHL Sponsor Green Light Process for research
sponsored by UHL
| Appendix 1 – Green Light Process First Site
Appendix 2 – Multi Centre Site Sponsor Green Light
Appendix 3 – Contracts Agreements Listing |
|
SOP S-1015 UHL Essential Documents
| Appendix 1 – TMF ISF Contents CTIMP
Appendix 1a TMF Non CE Marked Medical Device Studies
Appendix 2 – TMF ISF Contents non CTIMP
Appendix 2a – TMF ISF Contents Index for CE Marked and Proof of Concept Studies
Appendix 3 – Version Control Doc
Appendix 4 – File retention recommendations |
|
SOP S-1017 UHL Green Light Process for Amendments
| Appendix 1 – Amendments requiring MHRA authorisation only
Appendix 2 – Amendments requiring MHRA & REC authorisation
Appendix 3 – Amendments requiring REC favourable opinion
Appendix 4 – Amendments not normally requiring notification
|
|
S-1019: Procedure for the management of suspected fraud and
misconduct
| Appendix 1 – Suspected Fraud or Misconduct Initial Investigation Template
Appendix 2 – Suspected Fraud or Misconduct Interview Template
Appendix 3 – Evidence Listing Template |
|
S-1020: Process of assessing site feasibility
| Appendix 1 – Site Feasibility Assessment
Appendix 2 – Site Feasibility |
|
S-1021: Process of writing study protocols
| Appendix 3 – Protocol Training Log |
|
S-1023: Investigators brochure (IB)/summary of product
characteristics (SPC) preparation, review, approval and amendment
| Appendix 1 – Investigators Brochure Contents Template
Appendix 2 – Investigators Brochure Review template |
| S-1024: Study close down | Appendix 1 – Site Close Down Report Template
Appendix 1a – Site Close Down Report Non CE Marked Medical Device Studies Template
Appendix 2 – Site Close Down Visit Log
Appendix 3 – UHL Site Close Down Checklist for UHL Sponsored Non CTIMP Studies
Appendix 3a – UHL Site Close Down Checklist for UHL Sponsored CE Marked Device Studies |
| S-1025: Convening a data safety monitoring committee | Appendix 1 – Data Safety Monitoring Committee Charter Template |
| S-1026: Urgent safety measures | Appendix 1 – Urgent Safety Measures Template |
| S-1029: SOP for archiving of essential documents | Appendix 1 – Archiving Facility Checklist
Appendix 2 – Archiving Electronic Aspects of TMF
Appendix 3 – Pre-Archiving Checklist
Appendix 4 – Archiving process flowchart
Appendix 5 – Retrieval process flowchart
Appendix 6 – Archiving-Guidance-Timetable
Form A
Form B
Form C
Form D |
| S-1035: SOP for case report form production | Appendix 1 – Case Report Form Template
Appendix 2 – A guide to designing a case report form |
| S-1037: SOP for management of healthy volunteers in research studies of the bioequivalence, pharmacokinetics (PK) or pharmacodynamics of investigational medicinal products | Appendix 1 – TOPS Consent Form Template |
|
SOP S-1038 SOP Processing and Reporting SAEs, SADEs and
USADEs for Medical Device Studies
|
Appendix 1 – Event
Categorisation Flow Chart
Appendix 2 – Adverse event
Adverse Effect record
Appendix 3 – Serious Adverse
Event Report Form C
Appendix 4 – Multicentre line
listing
Appendix 5 – MHRA reporting
timelines table
Appendix 6 – UHL Medical
Device Process Flowchart
Appendix 7 – Template SAE
SADE Follow Up Information Request Email
|
| SOP S-1039 Sample management for research studies sponsored by UHL | Appendix 1a – FRIDGE Temperature Log
Appendix 1b – FREEZER Temperature Log
Appendix 1c – NITROGEN Log
Appendix 2 – Sample Tracking Log
Appendix 3 – Sample End of Study Sponsor Form
Appendix 4 – Shipping Instructions for Biological Samples
Appendix 5 – Human Tissue Disposal Form |
SOP S-1040 UHL Safety Reporting NON CE Marked Devices
| Appendix 1 – Event Categorisation Flow Chart
Appendix 2 – Adverse Event Adverse Effect Record
Appendix 3 – SAE Report Form C
Appendix 4 – SAE Form C Completion Guidance Document
Appendix 5 – Medical Device Sponsor Process Flowchart
Appendix 6 – Template SAE SADE Follow Up Information Request Email
Appendix 7 – Device Deficiency Form |
| SOP S-1041 Medical Device Studies Safety Reporting (NOT requiring MHRA approval) | Appendix 1 – Event Categorisation Flow Chart
Appendix 2 – Adverse Event Adverse Effect Record
Appendix 3 – SAE Report Form C
Appendix 4 – SAE Form C Completion Guidance Document
Appendix 5 – Multicentre Line Listing
Appendix 6 – Medical Device Sponsor Process Flowchart
Appendix 7 – Template SAE SADE Follow Up Information Request
Appendix 8 – Device Deficiency Form |
Afrikaans
Albanian
Amharic
Arabic
Armenian
Azerbaijani
Basque
Belarusian
Bengali
Bosnian
Bulgarian
Catalan
Cebuano
Chichewa
Chinese (Simplified)
Chinese (Traditional)
Corsican
Croatian
Czech
Danish
Dutch
English
Esperanto
Estonian
Filipino
Finnish
French
Frisian
Galician
Georgian
German
Greek
Gujarati
Haitian Creole
Hausa
Hawaiian
Hebrew
Hindi
Hmong
Hungarian
Icelandic
Igbo
Indonesian
Irish
Italian
Japanese
Javanese
Kannada
Kazakh
Khmer
Korean
Kurdish (Kurmanji)
Kyrgyz
Lao
Latin
Latvian
Lithuanian
Luxembourgish
Macedonian
Malagasy
Malay
Malayalam
Maltese
Maori
Marathi
Mongolian
Myanmar (Burmese)
Nepali
Norwegian
Pashto
Persian
Polish
Portuguese
Punjabi
Romanian
Russian
Samoan
Scottish Gaelic
Serbian
Sesotho
Shona
Sindhi
Sinhala
Slovak
Slovenian
Somali
Spanish
Sudanese
Swahili
Swedish
Tajik
Tamil
Telugu
Thai
Turkish
Ukrainian
Urdu
Uzbek
Vietnamese
Welsh
Xhosa
Yiddish
Yoruba
Zulu